Received Feb 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | z009549 | — |
No additional AE; HCP reports that the patient was inadvertently administered VAQTA after it suffered a Temperature Excursion. No additional information was provided at the time of the call. No additional AE/ no PQC. ? Names of vaccines involved (includ; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-Feb-2026, the patient was vaccinated with an improperly stored dose of Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA) (lot #z009549, expiration date: 07-Oct-2026) for prophylaxis (improper storage of product in use). No adverse event was reported. The vaccine underwent a temperature excursion of 52.7 degrees Farhrenheit for 1 hour and 30 minutes.